# Cosmo Bio

> Cosmo Bio is a VC fund in Tokyo backing Biotechnology, Medical and Biopharma. See 2 investments, round sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Tokyo, Japan
- Total investments: 2
- Last investment: Oct 2024
- Lead investor: 50%
- Last updated: Aug 2026
- Website: https://www.cosmobio.co.jp/
- Facebook: https://www.facebook.com/Cosmo-Bio-International-509656849161766/

Cosmo Bio is a VC fund in Tokyo focused on Biotechnology and Medical. Cosmo Bio provides the most up-to-date products and technical information available from world-class manufacturers, to laboratories, research institutes, life-science education and testing organizations throughout Japan and around the world. They are proud that their ability to supply a vast array of products and information allows us to serve theneeds of all of their customers. By making full use of their international network, coupled with the highest quality information, they support the life sciences community with a level of commitment and responsibility befitting a company that is trusted by its valued customers.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Medical | 1 | 50% |
| Biopharma | 1 | 50% |
| Pharmaceutical | 1 | 50% |
| Clinical Trials | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Corporate Round | 1 | 50% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Lab Biotech | Lab Biotech manufactures, conducts research, devises plans, and consults with pharmaceutical and food manufacturers. | $337.5K | Corporate Round | Oct 08, 2024 | https://lab-biotech.co.jp/ |
| Fimecs | FIMECS is a protein degradation technology-based drug discovery biotech focused on developing first-in-class protein degradation therapeutics for cancers and other difficult-to-treat diseases. The human body is comprised of at least 18,097 proteins.It has been revealed that 1,500 of them are related to certain diseases, nevertheless only about 300proteins have been regarded as druggable targets by small molecule drug discovery and all the rest have been undruggable. | $36.9M | Seed | Apr 01, 2018 | https://www.fimecs.com/ |

2 of 2 investments shown.

## Co-investors
- [Takeda](https://shizune.co/investors/profile/takeda-pharmaceutical) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund
- [Mizuho Capital](https://shizune.co/investors/profile/mizuho-capital) — VC Fund

## Featured in investor lists
- [Biotechnology Investors in Japan](https://shizune.co/investors/biotechnology-investors-japan)
- [Biotechnology VC Funds in Japan](https://shizune.co/investors/biotechnology-vc-funds-japan)
- [Biotech VC Funds in Japan](https://shizune.co/investors/biotech-vc-funds-japan)

## FAQ

### What does Cosmo Bio invest in?

Cosmo Bio invests primarily in Biotechnology, Medical and Biopharma startups, most often at Seed and Corporate Round stage. Most of the 2 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Cosmo Bio last invest?

The most recent investment recorded for Cosmo Bio closed in Oct 2024. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co